1. 376PDImpact of a molecular prescreening program (MPP) in the management of patients with non-glioblastoma brain tumors. (23rd October 2018) Authors: Benítez Montañez, J C; Vieito Villar, M; Hierro, C; Gonzalez Rodriguez, M; Matos, I; Braña Garcia, I; Suarez Rodriguez, C; Martinez Saez, E A; Perez-Gago, M C; Morales-Barrera, R; Ortiz, C; Suarez, C; Maldonado, X; Martinez-Ricarte, F; Auger, C; Azaro, A; Dienstmann, R; Carles, J; Garralda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 884PReal-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). (23rd October 2018) Authors: Procopio, G; Bamias, A; Schmidinger, M; Hawkins, R; Rodriguez Sanchez, A; Vazquez, S; Srihari, N; Kalofonos, H; Bono, P; Pisal, C; Hirschberg, Y; Dezzani, L; Ahmad, Q; Suarez Rodriguez, C; Jonasch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗